Literature DB >> 28296181

"White-Out" After Lung Transplantation: A Multicenter Cohort Description of Late Acute Graft Failure.

S E Verleden1, J Gottlieb2,3, A Dubbeldam4, G M Verleden1, H Suhling2,3, T Welte2,3, R Vos1, M Greer2,3.   

Abstract

Graft failure represents a leading cause of mortality after organ transplantation. Acute late-onset graft failure has not been widely reported. The authors describe the demographics, CT imaging-pathology findings, and treatment of patients presenting with the latter. A retrospective review was performed of lung transplant recipients at two large-volume centers. Acute late-onset graft failure was defined as sudden onset of bilateral infiltrates with an oxygenation index <200 without identifiable cause or concurrent extrapulmonary organ failure. Laboratory, bronchoalveolar lavage (BAL), radiology, and histology results were assessed. Between 2005 and 2016, 21 patients were identified. Median survival was 19 (IQR 13-36) days post onset. Twelve patients (57%) required intensive care support at onset, 12 (57%) required mechanical ventilation, and 6 (29%) were placed on extracorporeal life support. Blood and BAL analysis revealed elevated neutrophilia, with CT demonstrating diffuse ground-glass opacities. Transbronchial biopsy samples revealed acute fibrinoid organizing pneumonia (AFOP), organizing pneumonia, and diffuse alveolar damage (DAD). Assessment of explanted lungs confirmed AFOP and DAD but also identified obliterative bronchiolitis. Patients surviving to discharge without redo transplantation (n = 2) subsequently developed restrictive allograft syndrome. This study describes acute late-onset graft failure in lung allograft recipients, without known cause, which is associated with a dismal prognosis.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; lung (allograft) function/dysfunction; lung failure/injury; lung transplantation/pulmonology; patient survival

Mesh:

Year:  2017        PMID: 28296181     DOI: 10.1111/ajt.14268

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  4 in total

1.  Surviving White-out: How to Manage Severe Noninfectious Acute Lung Allograft Dysfunction of Unknown Etiology.

Authors:  Anil J Trindade; Whitney D Gannon; John W Stokes; Eric S Lambright; Katie A McPherson; Stephanie G Norfolk; Ivan M Robbins; Ciara M Shaver; Matthew Bacchetta
Journal:  Transplant Direct       Date:  2022-09-16

Review 2.  Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?

Authors:  Masaaki Sato
Journal:  Ann Transl Med       Date:  2020-03

Review 3.  Surveillance for acute cellular rejection after lung transplantation.

Authors:  Mark Greer; Christopher Werlein; Danny Jonigk
Journal:  Ann Transl Med       Date:  2020-03

4.  Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.

Authors:  Jens Gottlieb; Geert M Verleden; Michael Perchl; Christina Valtin; Alexander Vallee; Olivier Brugière; Carlos Bravo
Journal:  PLoS One       Date:  2021-12-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.